Malone C.S., Wall R.

J. Immunol. 168:3369-3375(2002) GeneRIF 973 · Mapped (4)
Unlike the B29 octamer motif the mb-1 octamer motif does not have the essential sequence required for OBF-1/Bob1 interaction therefore its promoter is not transactivated by OBF-1/Bob1. GeneRIF 973

Herren B., Burrows P.D.

Immunol. Res. 26:35-43(2002) GeneRIF 973 · Mapped (1)
B cell-restricted mb-1 gene: expression function and lineage infidelity. Review. GeneRIF 973

Gordon M.S., Kanegai C.M., Doerr J.R., Wall R.

Proc. Natl. Acad. Sci. U.S.A. 100:4126-4131(2003) GeneRIF 973 · Mapped (3)
There is a somatic hypermutation of this gene in B-cell lymphoma and multiple myeloma. GeneRIF 973

Tiacci E., Pileri S., Orleth A., Pacini R., Tabarrini A., Frenguelli F., Liso A., Diverio D., Lo-Coco F., Falini B.

Cancer Res. 64:7399-7404(2004) GeneRIF 973 · Mapped (22)
Results indicate that PAX5 is a more specific marker than CD79a for B-cell ALL diagnosis. GeneRIF 973

Vuillier F., Dumas G., Magnac C., Prevost M.C., Lalanne A.I., Oppezzo P., Melanitou E., Dighiero G., Payelle-Brogard B.

Blood 105:2933-2940(2005) GeneRIF 973 · Mapped (9)
lower levels of B-cell receptor surface expression observed in chronic lymphocytic leukemia are accounted for by an impaired glycosylation and folding of the mu and CD79a chains. GeneRIF 973

Kozlov I., Beason K., Yu C., Hughson M.

Cancer Genet. Cytogenet. 163:62-67(2005) GeneRIF 973 · Mapped (1)
FISH findings indicate that CD79a despite its specificity for B-cell differentiation represented the aberrant presence of a B-cell antigen in leukemias of distinct myeloid linage. GeneRIF 973

He G., Wu D., Sun A., Xue Y., Jin Z., Qiu H., Miao M., Tang X., Fu Z., Chen Z.

Cancer Genet. Cytogenet. 174:76-77(2007) GeneRIF 973 · Mapped (1)
Acute leukemia with t(8;21) coexpresses CytCD79a represent biphenotypic acute leukemia. GeneRIF 973

Polson A.G., Yu S.F., Elkins K., Zheng B., Clark S., Ingle G.S., Slaga D.S., Giere L., Du C., Tan C. et al.

Blood 110:616-623(2007) GeneRIF 973 · Mapped (3)
Anti-CD79b antibodies downregulated surface B-cell receptor and were trafficked to the lysosomal-like major histocompatibility complex class II-positive compartment of a mouse xenograft model of non-Hodgkin lymphoma. GeneRIF 973

Ilic V., Milosevic-Jovcic N., Petrovic S., Markovic D., Bila J., Boskovic D., Stefanovic G., Markovic O., Glibetic M.

Ann. Hematol. 86:905-912(2007) GeneRIF 973 · Mapped (7)
Ig-alpha was phosphorylated in all myeloma IgG BCR isolates the 31-kD variant being phosphorylated most frequently. It was not phosphorylated in normal control B cells. GeneRIF 973

Chung H.J., Chi H.S., Cho Y.U., Lee E.H., Jang S., Park C.J., Seo E.J.

Korean J Lab Med 27:388-393(2007) GeneRIF 973 · Mapped (1)
Median survival time of cytoplasmic CD79 alpha positive group was shorter than that of cytCD79a negative group in acute myeloid leukemia. GeneRIF 973

Leffers N., Gooden M.J., Mokhova A.A., Kast W.M., Boezen H.M., Ten Hoor K.A., Hollema H., Daemen T., van der Zee A.G., Nijman H.W.

Gynecol. Oncol. 113:256-263(2009) GeneRIF 973 · Mapped (1)
Nuclear MB1 expression was an independent predictor of worse survival in ovarian cancer. GeneRIF 973

Liang X.S., Caporaso N., McMaster M.L., Ng D., Landgren O., Yeager M., Chanock S., Goldin L.R.

Br. J. Haematol. 146:418-423(2009) GeneRIF 973 · Mapped (533)
Observational study of gene-disease association. (HuGE Navigator) GeneRIF 973

Tanaka T., Ichimura K., Sato Y., Takata K., Morito T., Tamura M., Kondo E., Ohara N., Yanai H., Sakai M. et al.

Pathol. Int. 59:804-808(2009) GeneRIF 973 · Mapped (9)
we determined the significance of loss or downregulation of CD79a overexpression of cyclinD1 and c-maf expression in bone marrow specimens with plasma cell myeloma GeneRIF 973

BRIGHT Consortium
Talmud P.J., Drenos F., Shah S., Shah T., Palmen J., Verzilli C., Gaunt T.R., Pallas J., Lovering R., Li K. et al.

Am. J. Hum. Genet. 85:628-642(2009) GeneRIF 973 · Mapped (10,092)
Observational study of gene-disease association. (HuGE Navigator) GeneRIF 973

Hoeller S., Zihler D., Zlobec I., Obermann E.C., Pileri S.A., Dirnhofer S., Tzankov A.

Histopathology 56:217-228(2010) GeneRIF 973 · Mapped (2)
CD79a may be helpful marker in the differential diagnosis of classical Hodgkin's lymphoma and primary mediastinal B-cell lymphoma GeneRIF 973

Davila S., Froeling F.E., Tan A., Bonnard C., Boland G.J., Snippe H., Hibberd M.L., Seielstad M.

Genes Immun. 11:232-238(2010) GeneRIF 973 · Mapped (4,258)
Observational study of gene-disease association. (HuGE Navigator) GeneRIF 973

Bailey S.D., Xie C., Do R., Montpetit A., Diaz R., Mohan V., Keavney B., Yusuf S., Gerstein H.C., Engert J.C. et al.

Diabetes Care 33:2250-2253(2010) GeneRIF 973 · Mapped (10,071)
Observational study of gene-disease association gene-environment interaction and pharmacogenomic / toxicogenomic. (HuGE Navigator) GeneRIF 973

Naylor T.L., Tang H., Ratsch B.A., Enns A., Loo A., Chen L., Lenz P., Waters N.J., Schuler W., Dorken B. et al.

Cancer Res. 71:2643-2653(2011) GeneRIF 973 · Mapped (3)
STN produced significant antitumor effects in a mouse xenograft model of CD79A/B-mutated DLBCL. GeneRIF 973

Chowdhury B., Zhang Z., Mukherjee A.B.

FEBS Lett. 582:611-615(2008) MINT MINT-6491159 · Mapped (3)
MINT-6491150. Fibronectin (uniprotkb:P02751) and IgA (uniprotkb:P11912) bind (MI:0407) by competition binding (MI:0405). From mint MINT MINT-6491159